Navigation Links
Drug Given 24 Hours After Stroke Helps Repair Brain Tissue
Date:9/3/2008

Bryostatin may also work in patients with Alzheimer's and traumatic injury, study says

WEDNESDAY, Sept. 3 (HealthDay News) -- A little-used cancer drug called bryostatin can repair brain tissue if it's administered within 24 hours after a stroke, according to U.S. researchers.

Current stroke treatments must be administered within three hours and aren't able to repair damaged brain tissue, the scientists said.

"Today's stroke patient has precious minutes to receive care without suffering irreversible damage or death. One of the greatest challenges in modern medical practice is finding an effective treatment that extends that treatment time and repairs damage. Bryostatin could be an answer," Dr. Daniel Alkon, scientific director at the Blanchette Rockefeller Neurosciences Institute, said in an institute news release.

In an article in the Sept. 3 issue of the Proceedings of the National Academy of Sciences, Alkon and colleague Professor Miao-Kun Sun describe how bryostatin -- which is being investigated as a treatment for Alzheimer's disease -- repairs the brain and improves memory.

More than 780,000 strokes occur each year in the United States. Stroke is the third leading cause of death in the United States and the leading cause of long-term disability in the developing world. Almost 75 percent of all strokes occur in people older than 65, and the risk of suffering a stroke more than doubles each decade after age 55, according to background information in the news release.

"We're facing an aging Baby Boomer population, an influx of 55-plus Americans, and treatment that is less time-restrictive and able to repair the brain if a stroke destroys tissue is urgently needed," Alkon said.

In animal tests, bryostatin rescued dying neurons, stimulated the growth of new neuron connections, and restored memory. The drug is effective when administered up to 24 hours after a stroke, according to the researchers.

The drug may also prove effective in preventing and/or reversing brain degeneration in patients with Alzheimer's disease and traumatic brain injury, Alkon said.

The researchers are in discussion with the U.S. Food and Drug Administration to begin clinical trials of the drug.

More information

The U.S. Food and Drug Administration has more about stroke prevention and treatment.



-- Robert Preidt



SOURCE: Blanchette Rockefeller Neurosciences Institute, news release, Sept. 3, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. More sick leave given to men by male GPs compared with female counterparts
2. 10 Million Children Must Be Given a Chance
3. Promising new TB drug given special status by US and European regulators
4. Over 300 Children Are Given New Smiles
5. Bariatric Surgery Center of Excellence Designation Given to Montefiore by the American College of Surgeons
6. Pelosi: By Literally Fixing Broken Hearts, Dr. DeBakey Has Given Hope and Health to Millions
7. PartsSource Given 2008 Leading Edge Award for Second Straight Year
8. Less Intensive Treatment Given Diabetic Women With Heart Disease
9. PartsSource Given 2008 World Class Customer Service Award for Second Straight Year
10. Nursing Loan Forgiveness Programs -- More Applicants Needed by June 30, 2008
11. Limiting Residents Hours Has Little Impact on Patient Mortality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... a new 21st century approach to infusing high speed technology into the fabric ... exclusively dedicated to the advancement of healthcare and wellness in a yet-to-be-named, health ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... lecture to primary eye care practitioners on the latest breakthroughs in the prevention, ... Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, FACS, Chief ...
(Date:1/17/2017)... , ... January 17, 2017 , ... SC&H Group, a ... as a Principal in its IT Advisory Services practice . Rossi is the ... as market demand for strategic IT guidance grows, and the practice continues to expand.     ...
(Date:1/17/2017)... ... January 17, 2017 , ... Lynx Technology Partners ... US security companies for consecutive years, today announced the appointment of four members ... board nomination process to a close and positions Lynx for even faster growth ...
(Date:1/16/2017)... Creek, MI (PRWEB) , ... January 17, 2017 , ... ... abuse located in Southwest Michigan, joined other volunteers and organizations in support of the ... hundreds of children and families dressed up in colorful costumes of all designs coming ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Jan. 17, 2017   Anesthesia Business Consultants ... practice management for the anesthesia and pain management ... remains a "clinical conundrum" (as described recently in ... practitioners to think carefully before recommending medical marijuana ... by the National Academies of Sciences, Engineering and ...
(Date:1/17/2017)... 17, 2017  In a preview of the upcoming Society ... Astute Medical, Inc., developer of the NephroCheck Test, today highlighted ... identifies hospital patients at risk of developing moderate to severe ... month at the Hawaii Convention Center ... January 25. AKI is one of the top ...
(Date:1/17/2017)... , January 17, 2017 OilPrice.com ... potentially earn millions in revenue with the planned upcoming ... numbers of strokes with a simple test that is ... with latest developments in the markets today include:  Amgen ... AZN ), Cancer Genetics, Inc. (NASDAQ: ...
Breaking Medicine Technology: